Literature DB >> 15709171

Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway.

Bailong Sun1, Jun Nishihira, Takashi Yoshiki, Masao Kondo, Yuji Sato, Fumiaki Sasaki, Satoru Todo.   

Abstract

PURPOSE: Macrophage migration inhibitory factor (MIF) plays an important role not only in the immune system but also in tumorigenesis. In this study, we investigated the potential role of MIF in association with tumor invasion and metastasis.
METHODS: To assess the function of MIF, we knocked down the MIF mRNA using small interfering RNA (siRNA). Twenty-one base siRNA specific for the mRNA sequence of mouse MIF was introduced to a murine colon cancer cell line, colon 26. Tumor cell invasion was evaluated using a transwell method (8-microm pores) coated with Matrigel on the upperside membrane and with fibronectin on the underside membrane. Moreover, we investigated the signal transduction of lysophosphatidic acid (LPA) relevant to the Rho-dependent pathway and further examined the effect of MIF siRNA on this signal transduction system. In vivo, the tumor cells were pretreated with MIF siRNA and injected into the portal vein, and the effects on metastasis to the liver were evaluated.
RESULTS: We found that MIF siRNA markedly reduced the invasion of the cells from the upperside to lowerside membranes. We revealed that the Rho-dependent pathway activated by LPA was suppressed by MIF siRNA. Next, we found that the tyrosine-phosphorylation of focal adhesion kinase and LPA-induced expressions of integrin beta1 were significantly suppressed by MIF siRNA. In vivo, metastasis to the liver was significantly inhibited by pretreatment of the cells with MIF siRNA.
CONCLUSION: Taken together, these results suggest that MIF promotes tumor invasion and metastasis via the Rho-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15709171

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  35 in total

1.  Proteomic analysis of osteogenic sarcoma: association of tumour necrosis factor with poor prognosis.

Authors:  Justin M M Cates; David B Friedman; Erin H Seeley; William D Dupont; Herbert S Schwartz; Ginger E Holt; Richard M Caprioli; Pampee P Young
Journal:  Int J Exp Pathol       Date:  2010-03-26       Impact factor: 1.925

2.  Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas.

Authors:  Xiao-Bing Wang; Xiao-Ying Tian; Yang Li; Bin Li; Zhi Li
Journal:  J Neurooncol       Date:  2011-07-03       Impact factor: 4.130

3.  Role of macrophage migration inhibitory factor in the regulatory T cell response of tumor-bearing mice.

Authors:  Susanna Choi; Hang-Rae Kim; Lin Leng; Insoo Kang; William L Jorgensen; Chul-Soo Cho; Richard Bucala; Wan-Uk Kim
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

Review 4.  The emerging roles of Jab1/CSN5 in cancer.

Authors:  Lin Wang; Jun-Nian Zheng; Dong-Sheng Pei
Journal:  Med Oncol       Date:  2016-07-13       Impact factor: 3.064

5.  Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization.

Authors:  Millicent Winner; Albert C Koong; Beatriz E Rendon; Wayne Zundel; Robert A Mitchell
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

6.  Long non-coding RNA MALAT1 interaction with miR-429 regulates the proliferation and EMT of lung adenocarcinoma cells through RhoA.

Authors:  Haiping Xiao; Qihang Zhu; Jianlong Zhou
Journal:  Int J Clin Exp Pathol       Date:  2019-02-01

Review 7.  Macrophage migration inhibitory factor manipulation and evaluation in tumoral hypoxic adaptation.

Authors:  Millicent Winner; Lin Leng; Wayne Zundel; Robert A Mitchell
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

8.  Expression of macrophage migration inhibitory factor relates to survival in high-grade osteosarcoma.

Authors:  Ilkyu Han; Mi Ra Lee; Kwang Woo Nam; Joo Han Oh; Kyung Chul Moon; Han-Soo Kim
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

9.  Activation of ERK-FAK signaling pathway and enhancement of cell migration involved in the early interaction between oral keratinocytes and Candida albicans.

Authors:  Jing Shi; Xin Zeng; Min Zhou; Qianming Chen
Journal:  Mycopathologia       Date:  2008-07-09       Impact factor: 2.574

10.  Modulation of expression and cellular distribution of p21 by macrophage migration inhibitory factor.

Authors:  Elliott Taranto; Jin R Xue; Eric F Morand; Michelle Leech
Journal:  J Inflamm (Lond)       Date:  2009-08-24       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.